Monday, June 20, 2016

BRIEF-Caladrius unit to manufacture Phase 3 cell therapy product for Kiadis Pharma

* Kiadis Pharma appoints PCT as its contract manufacturing

organization in the United States

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)